Ivana Zagorac
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Drug-Gated, Modular STAb-T Immunotherapy With External Control.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 22, 2026
Simultaneous secretion of a PD-L1 x 4-1BB bispecific antibody improves antileukemic efficacy of STAb-T cells secreting a CD19-specific T-cell engager.
Journal: Oncoimmunology
Published: October 27, 2025
mRNA-engineered T lymphocytes secreting bispecific T cell engagers with therapeutic potential in solid tumors.
Journal: Frontiers in immunology
Published: August 12, 2025
Bispecific antibodies and nanotechnology: a strategic alliance in cancer immunotherapy.
Journal: Molecular cancer
Published: June 30, 2025
Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance.
Journal: Molecular cancer therapeutics
Published: August 04, 2021
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia.
Journal: Scientific reports
Published: June 21, 2019
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
Journal: Nature communications
Published: September 15, 2017
Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics.
Journal: Cell reports
Published: November 12, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026